NextPlat Corp (NASDAQ:NXPL) Short Interest Down 13.7% in February

NextPlat Corp (NASDAQ:NXPL) was the target of a significant decline in short interest during the month of February. As of February 15th, there was short interest totalling 115,500 shares, a decline of 13.7% from the January 31st total of 133,800 shares. Based on an average daily volume of 379,600 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.8% of the company’s stock are short sold.

NextPlat Stock Performance

Shares of NextPlat stock traded up $0.01 during mid-day trading on Thursday, hitting $0.95. 18,806 shares of the stock were exchanged, compared to its average volume of 422,263. NextPlat has a 12 month low of $0.71 and a 12 month high of $2.68. The company has a 50-day simple moving average of $1.09 and a 200 day simple moving average of $1.13. The company has a market capitalization of $24.64 million, a P/E ratio of -1.40 and a beta of 0.76. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.04 and a current ratio of 3.70.

Institutional Trading of NextPlat

Hedge funds have recently bought and sold shares of the business. Renaissance Technologies LLC purchased a new stake in shares of NextPlat during the 4th quarter valued at $30,000. Geode Capital Management LLC increased its holdings in NextPlat by 54.6% during the fourth quarter. Geode Capital Management LLC now owns 165,459 shares of the company’s stock worth $179,000 after buying an additional 58,402 shares during the last quarter. Finally, Omnia Family Wealth LLC bought a new stake in NextPlat in the third quarter worth about $132,000. 1.30% of the stock is currently owned by institutional investors.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.